Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albuferon + Ribavirin in HCV Genotype 2/3
NCT00656006Phase 2Completed
- Sponsor
- Human Genome Sciences
- Start
- Nov 2005
- Primary completion
- Apr 2007
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of albinterferon alfa-2b in hepatitis C (HCV), sponsored by Human Genome Sciences. Started Nov 2005; status: completed.
02
Drugs
albinterferon alfa-2b
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00656006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00656006.